ACE2 and COVID-19: ACE2 is the most well-studied receptor for SARS-CoV-2, yet it is not an ideal therapeutic target for COVID-19, since it is widely expressed in multiple organs and plays crucial roles in regulating blood pressure and preventing heart/kidney injury (Imai et al., 2005; Li et al., 2020d).